A 32-year-old mother was diagnosed with so-called “triple negative” breast cancer which only affects 15% of patients.
Conventional chemotherapy treatment did not prevent a new tumor from growing.
His only hope lies in an experimental treatment which is not reimbursed in his case.
His life has a price. Last summer, fate fell on a family from Rouvroy, in Pas-de-Calais. Marilyn, 32 years old and mother of three, saw her life turn upside down when she learned that she had breast cancer. First reassuring, the doctors' diagnoses became more and more worrying. The worst news fell next, when the young woman noticed that conventional treatments were not working.
Marilyn and her family's descent into hell began on July 17, when the thirty-something "felt a lump" in her chest.
Between clinical examinations and ultrasounds, hope lasted until the end of September, before the first diagnosis of a "benign tumor" was erased after a first operation by another observation, much more serious: a cancer without metastasis but "triple negative".
"A median overall survival of around 14 months"
Marilyn went through chemotherapy until the end of November, to no avail.
A new ultrasound revealed the presence of a 4 cm tumor.
"Apart from giving me the side effects, the chemotherapy did not act on my cancer", laments the young mother before starting a series of chemos in early December.
"Triple negative" cancer cases affect only 15% of patients, and present "a median overall survival of around 14 months and a 5-year survival rate of 11.3%", according to the transparency commission of the High Authority for Health (HAS). The specialists consulted by Marilyn advised her to test an experimental drug, Keytruda. This treatment, which does not yet benefit from marketing authorization, nevertheless received an early access decision from the HAS last November "in view of the benefit provided, in particular in overall survival compared to chemotherapy. only ".
Except that, in Marilyn's case, access to this treatment is very expensive.
“This drug is not reimbursed to me.
It comes back to me more or less at 3,500 euros per dose, at the rate of one dose every 15 days, ”she explains.
To finance medicine and find a little hope, the young woman has launched an appeal for help in the form of an online pot.
Of the 35,000 euros needed, she has already collected nearly 25,000 euros in donations.
A generosity that could allow this mother to forget her greatest fear: not seeing her children grow up.
Health
Pink October: "For fear of breast cancer", they gave up deodorants containing aluminum salts
Nice
Nice: What is this departmental cancer institute, the first of its type in France, which will see the light of day in the Alpes-Maritimes?
Processing
Breast cancer
Cancer
Health
0 comment
0 share
Share on Messenger
Share on Facebook
Share on twitter
Share on Flipboard
Share on Pinterest
Share on Linkedin
Send by Mail
To safeguard
A fault ?
To print